About Praveen Tyle
Form D filings for Maxwell Biosciences from 2022 to 2023 list Praveen Tyle as director.
Praveen Tyle first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Praveen Tyle in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Praveen Tyle works with at each company, as listed on that company's latest Form D.
Maxwell Biosciences, Inc. · Form D, Jul 14, 2023
JM
Joshua McClure
President and CEO, director
KM
Kate McKinley
Director
BH
Barbara Holcomb
Director
AB
Annelise Barron
Director